McKay Urology is currently engaged in a number of clinical trials, which are summarized below. The summaries are organized by disease/condition, and they include the following information:

• Trial name
• Purpose of the trial
• Trial sponsor (and a link to their website further information, if applicable)
• Randomization: When a patient agrees to participate in a trial, he/she is randomly assigned to one of the different treatment plans, called "arms," of the study. Some treatment arms are blinded, so the patient and doctor do not know if the patient is on the study drug or on a placebo.
• Protocol: An alphanumeric code that identifies a given trial. Protocol also refers to the study design, which includes treatment arms, follow-up schedule, inclusion/exclusion criteria, end points, and so forth.
• Phase: Clinical trials are designed as one of four phases. Phase I studies, which occur early in drug design, are single-arm studies that look primarily at toxicity and also for trends indicative of efficacy. A Phase II study is a multi-arm study that looks for evidence of efficacy and the effects of drug dosage. A Phase III study, also known as a "registration trial," is a placebo-controlled trial that is designed as a final study to obtain data necessary for FDA approval. Phase IV trials follow FDA approval and look for applications of an approved drug for new indications.
• Enrollment status: Whether the trial is currently enrolling, or if accrual is complete
• Contact number for participation consideration: Name, telephone number, and e-mail address of the research coordinator who is overseeing the trial at our site